news released January 28, 2015, by the American Society of Reproductive Medicine
The Society for Assisted Reproductive Technology (SART) last week released for the first time an ART Patient Predictor — a cutting edge tool designed to allow patients to obtain a preliminary assessment of their individual prospects for IVF success.
The Predictor uses an algorithm based on a database that includes information on more than a million treatment cycles. The tool uses a patient’s age, height, weight, number of prior pregnancies and infertility diagnoses to predict an individual patient’s success after one, two, and three treatment cycles, as well as the chance for multiple pregnancies when one or two embryos are transferred.
The Predictor does not compare clinics; differences in patient populations and treatment modalities make it difficult make meaningful comparisons.
Future additions to the Predictor will include more detailed patient input to create more robust predictions.
SART has been collecting outcomes data on ART treatments in the U.S. since 1987 as part of its mission to improve patient care. Now, the Predictor allows patients to harness the data’s power directly and specifically for themselves.
“We realized we could simplify the reporting of results and tailor it to individual patients. We all know that each couples’ reason for infertility will affect their individual treatment outcomes. Rather than look at a complicated multifactorial table and try to figure out what that might mean for them, patients can now enter a few key pieces of information about themselves and get an estimate of their prospects for success,” stated Jim Toner, MD, PhD, President of SART.
“While all patients are unique and no algorithm can account for everything, this is an accessible, easy to use tool to allow them to begin their exploration. The Predictor is no substitute for a full diagnosis from a skilled clinician,” cautioned Bradley Van Voorhis, MD, SART President-elect. “Patients need to consult with a SART member clinic prior to making final decisions about their treatment.”
SART’s new Patient Predictor Tool is free to use and may be found at www.sart.org. Click on the button, “Predict My Success.”
The Society for Assisted Reproductive Technology, an affiliate of the American Society for Reproductive Medicine, is the primary organization of professionals dedicated to the practice of assisted reproductive technologies (ART) in the United States.